Aaron Rosenberg's most recent trade in BeiGene Ltd - ADR was a trade of 119,873 Share Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene Ltd - ADR | Aaron Rosenberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 119,873 | 119,873 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Aaron Rosenberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 63,674 | 230,802 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd - ADR | Aaron Rosenberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 48,581 | 167,128 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd - ADR | Aaron Rosenberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 220,987 | 220,987 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Aaron Rosenberg | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 118,547 | 118,547 (0%) | 0% | 0 | Ordinary Shares |